Endovascular treatment for extensive aortoiliac artery reconstruction: a single-center experience based on 1712

Sebastian Sixt1, Hans Krankenberg, Charlotte Möhrle

  • 1Department of Angiology, Heart Center Bad Krozingen, Germany. sixt@herz-hh.de

Insights

Endovascular therapy for aortoiliac occlusive disease shows good outcomes, even for complex TASC C and D lesions. Experienced centers can extend interventions to complex aortic bifurcation reconstructions.

Area of Science:

  • Vascular Surgery
  • Endovascular Interventions
  • Aortoiliac Occlusive Disease

Background:

  • Aortoiliac occlusive disease (AIOD) significantly impacts patient mobility and quality of life.
  • Endovascular therapy offers a less invasive approach compared to open surgical reconstruction.

Purpose of the Study:

  • To evaluate clinical and technical outcomes of endovascular therapy for AIOD.
  • To assess outcomes including complex aortic bifurcation reconstruction.
  • To stratify results based on TransAtlantic Inter-Society Consensus (TASC II) lesion morphology.

Main Methods:

  • Retrospective analysis of 1184 patients undergoing 1712 endovascular procedures for AIOD (1996-2006).
  • Primary endpoint: 1-year duplex-based primary patency.
  • Secondary endpoints: technical success, secondary patency, target lesion revascularization (TLR).

Main Results:

  • 1-year and 2-year restenosis, TLR, and patency rates were similar across TASC II A-D subgroups.
  • Symptom-driven TLR was 8% at 1 year and 9% at 2 years, with high secondary patency rates (96% and 91%).
  • Overall survival without restenosis, amputation, or surgery was higher for TASC II A+B lesions (69.6%) compared to C+D (62.8%).

Conclusions:

  • Endovascular intervention is effective for AIOD, including complex TASC C and D lesions.
  • Experienced endovascular centers can safely perform complex reconstructions of the distal aorta and aortic bifurcation.
  • Indications for percutaneous intervention in AIOD can be expanded.
Abstract